A Multinational, Phase 3, Randomized, Double Blind, Placebo Controlled, Efficacy and Safety Study of Enzalutamide in Patients With Nonmetastatic Castration Resistant Prostate Cancer
Principal Investigator
Martin GleaveOverview
Study Start/End
Jan 24, 2014 to Jan 10, 2019Locations
Diamond Health Care Centre, Vancouver General Hospital
Name/Title
Maureen Palmer, Research CoordinatorPhone
604-875-5675Purpose of Study
The purpose of this study is to assess the safety and efficacy of enzalutamide in patients with non metastatic prostate cancer.
Eligibility
Visit ClinicalTrials.gov for more information.
Disclaimer
Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.